The QBE Insurance Group Ltd (ASX:QBE) share price fell 3% to $10.30 this morning after the company released its full year results. Here’s what you need to know: Revenue rose 2% to $17,267 million Loss after tax of $1,249 million Loss of 91.5 cents per share Dividends per share of 26 cents, partly franked Net tangible assets of US$4.29 (A$5.47) per share Combined operating ratio of 104.8% (94% in 2016) Sale of Latin American operations to Zurich Insurance for $409m Outlook for combined operating ratio between 95% and 97.5%, and net return on investment portfolio of 2.5% to 3% So…
You can continue reading this story now by entering your email below
The QBE Insurance Group Ltd (ASX:QBE) share price fell 3% to $10.30 this morning after the company released its full year results. Here’s what you need to know:
- Revenue rose 2% to $17,267 million
- Loss after tax of $1,249 million
- Loss of 91.5 cents per share
- Dividends per share of 26 cents, partly franked
- Net tangible assets of US$4.29 (A$5.47) per share
- Combined operating ratio of 104.8% (94% in 2016)
- Sale of Latin American operations to Zurich Insurance for $409m
- Outlook for combined operating ratio between 95% and 97.5%, and net return on investment portfolio of 2.5% to 3%
It was another nightmare year for QBE, with massive storms landing the company with significant losses despite the company’s reinsurance program. QBE also took a $160 million hit on the Ogden decision in the UK, which will result in all insurers having to adjust their personal injury claims estimates significantly higher. On the upside, industry pricing is expected to increase as a result.
As part of its long-running plan to simplify the company and return sustainably to profit, QBE announced that it was selling its Latin American businesses in Argentina, Brazil, Colombia, Ecuador, and Mexico for $409 million, subject to regulatory approval.
The minimal selling activity today suggests that the market has already priced in much of the impact to QBE. However, it might also be that investors expect considerable offsetting benefits from an upturn in the insurance industry, as well as a reduction in the US corporate tax rates. The QBE turnaround seems to be taking its time coming to fruition.
I think QBE’s an interesting business particularly given US corporate tax cuts, improvements in industry pricing, the divestment of the troublesome Latin American businesses, and the possibility of rising interest rates.
There is a good case to be made for a turnaround story and I am keeping half an eye on the company from that perspective. However, I also think that the turnaround could be a long and painful one and it may take several more years before QBE really finds itself running on all cylinders. That’s something to keep in mind.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor Sean O'Neill has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.